It’s estimated that 90% of retail investors lose money. We help you beat those odds with concise research, education and more. Click here to see our offerings.
- Based out of NC, VTVT therapeutics is a clinical-stage biotech, focused on orally administered small molecule drug candidates to fill significant unmet medical needs
- VTVT has an array of assets (partnered and independent programs) targeting Type-1 Diabetes (T1D), Cystic Fibrosis Related Diabetes (CFRD), PMM (a genetic disorder), skin diseases, and COPD